This startup develops an end-to-end integrated microfluidics chip that uses CRISPR-based DNA editing to write, read, and store digital data in bacterial DNA. This technology offers researchers a novel method for high-density, long-term data storage and retrieval.
Funding
$37.7K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Existing methods for digital data storage face limitations in terms of density, longevity, and energy consumption. Traditional silicon-based storage is also susceptible to obsolescence and requires significant infrastructure for maintenance and access.
Solution
BioCompute Inc. is developing a microfluidics-based platform that leverages CRISPR technology to write, read, and store digital information within bacterial DNA. This approach offers a high-density, long-term data storage solution with the potential for significantly reduced energy consumption compared to conventional methods. The integrated microfluidic chip automates the DNA writing and reading processes, while CRISPR-based editing ensures precise data encoding and retrieval. By harnessing the inherent stability and density of DNA, BioCompute aims to create a scalable and sustainable alternative for archival data storage.
Target Audience
The primary target audience includes researchers and organizations in need of high-density, long-term data storage solutions, such as archival institutions, research facilities, and enterprises managing large datasets.
Features
- Integrated microfluidic chip for automated DNA writing, reading, and storage
- CRISPR-based DNA editing for precise data encoding and retrieval
- High-density data storage within bacterial DNA
- Long-term data preservation capabilities
- Potential for reduced energy consumption compared to traditional storage methods
- Solid state nanopores for reading DNA